The Rosen Law Firm is currently evaluating potential securities claims on behalf of shareholders who purchased Disc Medicine, Inc. (NASDAQ: IRON) stock. The investigation centers on allegations that the company provided misleading business information to the public regarding its development pipeline. Investors affected by the February market correction may be eligible for compensation through a proposed class action lawsuit, which operates on a contingency fee basis.

Those who held securities during the relevant period are encouraged to contact attorney Phillip Kim to discuss their legal standing. While the firm highlights its history of securities litigation and settlement recoveries, the ongoing inquiry remains in the preliminary stages. Prospective class members can submit their information through the firm’s online portal to determine if they qualify for participation in the recovery effort.